Freedom of Information Request: 0327 2019/20
I would like to make a Freedom of Information request with regards to the usage of Chimeric Antigen Receptor T-Cell (CAR T-cell) therapies. Could you please provide me with the following numbers of patients treated in the last 12 months (latest 12 months possible) with the following drugs and where possible please could you split by the indication for which the drug was provided:
| Number of patients treated | B-cell acute lymphoblastic leukaemia (ALL) | Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) | Primary mediastinal large B-cell lymphoma (PMBCL) | All Indications
(Total) |
| Yescarta (axicabtagene ciloleucel) | Not Applicable | * | * | * |
| Kymriah (tisagenlecleucel) | * | * | * | * |
Where the number of patients treated is less than 6 (six) please could you redact this amount by replacing with an asterisk (“*”)
